Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine

01:02 EST 1 Jan 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Vaxenta Biotechnologies announces the filing of a Patent Cooperation Treaty (PCT) application (SN: PCT/US13/55632) to the World Intellectual Property Organization (WIPO) covering a biological immunotherapeutic platform against c...

Other Sources for this Article

Vaxenta Biotechnologies
Boris Markosian, CEO, 818-823–3632
Fax: 858-227–9774
Email: bmarkosi@vaxenta.com

NEXT ARTICLE

More From BioPortfolio on "Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story